Cargando…

Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care

BACKGROUND: Aging population has led to an increased proportion of older adults and cognitively impaired. We designed a brief and flexible two-stage cognitive screening scale, the Dual-Stage Cognitive Assessment (DuCA), for cognitive screening in primary care settings. METHOD: In total, 1,772 commun...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Liang, Zhang, Zhen, Huang, Lin, Li, Qinjie, Guo, Yi-Han, Guo, Qi-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210296/
https://www.ncbi.nlm.nih.gov/pubmed/37231438
http://dx.doi.org/10.1186/s12888-023-04883-w
_version_ 1785047039801819136
author Cui, Liang
Zhang, Zhen
Huang, Lin
Li, Qinjie
Guo, Yi-Han
Guo, Qi-Hao
author_facet Cui, Liang
Zhang, Zhen
Huang, Lin
Li, Qinjie
Guo, Yi-Han
Guo, Qi-Hao
author_sort Cui, Liang
collection PubMed
description BACKGROUND: Aging population has led to an increased proportion of older adults and cognitively impaired. We designed a brief and flexible two-stage cognitive screening scale, the Dual-Stage Cognitive Assessment (DuCA), for cognitive screening in primary care settings. METHOD: In total, 1,772 community-dwelling participants were recruited, including those with normal cognition (NC, n = 1,008), mild cognitive impairment (MCI, n = 633), and Alzheimer’s disease (AD, n = 131), and administered a neuropsychological test battery and the DuCA. To improve performance, the DuCA combines visual and auditory memory tests for an enhanced memory function test. RESULTS: The correlation coefficient between DuCA-part 1 and DuCA-total was 0.84 (P < 0.001). The correlation coefficients of DuCA-part 1 with Addenbrooke’s Cognitive Examination III (ACE-III) and Montreal Cognitive Assessment Basic (MoCA-B) were 0.66 (P < 0.001) and 0.85 (P < 0.001), respectively. The correlation coefficients of DuCA-total with ACE-III and MoCA-B were 0.78 (P < 0.001) and 0.83 (P < 0.001), respectively. DuCA-Part 1 showed a similar discrimination ability for MCI from NC (area under curve [AUC] = 0.87, 95%CI 0.848–0.883) as ACE III (AUC = 0.86, 95%CI 0.838–0.874) and MoCA-B (AUC = 0.85, 95%CI 0.830–0.868). DuCA-total had a higher AUC (0.93, 95%CI: 0.917–0.942). At different education levels, the AUC was 0.83–0.84 for DuCA-part 1, and 0.89–0.94 for DuCA-total. DuCA-part 1 and DuCA-total’s ability to discriminate AD from MCI was 0.84 and 0.93, respectively. CONCLUSION: DuCA-Part 1 would aid rapid screening and supplemented with the second part for a complete assessment. DuCA is suited for large-scale cognitive screening in primary care, saving time and eliminating the need for extensively training assessors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-04883-w.
format Online
Article
Text
id pubmed-10210296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102102962023-05-26 Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care Cui, Liang Zhang, Zhen Huang, Lin Li, Qinjie Guo, Yi-Han Guo, Qi-Hao BMC Psychiatry Research BACKGROUND: Aging population has led to an increased proportion of older adults and cognitively impaired. We designed a brief and flexible two-stage cognitive screening scale, the Dual-Stage Cognitive Assessment (DuCA), for cognitive screening in primary care settings. METHOD: In total, 1,772 community-dwelling participants were recruited, including those with normal cognition (NC, n = 1,008), mild cognitive impairment (MCI, n = 633), and Alzheimer’s disease (AD, n = 131), and administered a neuropsychological test battery and the DuCA. To improve performance, the DuCA combines visual and auditory memory tests for an enhanced memory function test. RESULTS: The correlation coefficient between DuCA-part 1 and DuCA-total was 0.84 (P < 0.001). The correlation coefficients of DuCA-part 1 with Addenbrooke’s Cognitive Examination III (ACE-III) and Montreal Cognitive Assessment Basic (MoCA-B) were 0.66 (P < 0.001) and 0.85 (P < 0.001), respectively. The correlation coefficients of DuCA-total with ACE-III and MoCA-B were 0.78 (P < 0.001) and 0.83 (P < 0.001), respectively. DuCA-Part 1 showed a similar discrimination ability for MCI from NC (area under curve [AUC] = 0.87, 95%CI 0.848–0.883) as ACE III (AUC = 0.86, 95%CI 0.838–0.874) and MoCA-B (AUC = 0.85, 95%CI 0.830–0.868). DuCA-total had a higher AUC (0.93, 95%CI: 0.917–0.942). At different education levels, the AUC was 0.83–0.84 for DuCA-part 1, and 0.89–0.94 for DuCA-total. DuCA-part 1 and DuCA-total’s ability to discriminate AD from MCI was 0.84 and 0.93, respectively. CONCLUSION: DuCA-Part 1 would aid rapid screening and supplemented with the second part for a complete assessment. DuCA is suited for large-scale cognitive screening in primary care, saving time and eliminating the need for extensively training assessors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-04883-w. BioMed Central 2023-05-25 /pmc/articles/PMC10210296/ /pubmed/37231438 http://dx.doi.org/10.1186/s12888-023-04883-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cui, Liang
Zhang, Zhen
Huang, Lin
Li, Qinjie
Guo, Yi-Han
Guo, Qi-Hao
Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
title Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
title_full Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
title_fullStr Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
title_full_unstemmed Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
title_short Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
title_sort dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210296/
https://www.ncbi.nlm.nih.gov/pubmed/37231438
http://dx.doi.org/10.1186/s12888-023-04883-w
work_keys_str_mv AT cuiliang dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare
AT zhangzhen dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare
AT huanglin dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare
AT liqinjie dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare
AT guoyihan dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare
AT guoqihao dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare